Balchem (BCPC)
(Delayed Data from NSDQ)
$170.55 USD
-1.48 (-0.86%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $170.43 -0.12 (-0.07%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$170.55 USD
-1.48 (-0.86%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $170.43 -0.12 (-0.07%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth B Momentum D VGM
Zacks News
Here's Why Momentum in Blachem (BCPC) Should Keep going
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Blachem (BCPC) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Can Blachem (BCPC) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Blachem (BCPC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
What Makes Blachem (BCPC) a New Strong Buy Stock
by Zacks Equity Research
Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Momentum Stock to Buy for February 22nd
by Zacks Equity Research
NVDA, APAM and BCPC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 22, 2024.
Has Balchem (BCPC) Outpaced Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Blachem (BCPC) and ELEMENTIS (ELMTY) have performed compared to their sector so far this year.
Here's What Could Help Blachem (BCPC) Maintain Its Recent Price Strength
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Blachem (BCPC) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
CE or BCPC: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CE vs. BCPC: Which Stock Is the Better Value Option?
Blachem (BCPC) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of -5.75% and 3.01%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Celanese (CE) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Celanese (CE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Blachem (BCPC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Blachem (BCPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Valvoline (VVV) Q1 Earnings Match Estimates
by Zacks Equity Research
Valvoline (VVV) delivered earnings and revenue surprises of 0% and 0.68%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
CE or BCPC: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CE vs. BCPC: Which Stock Is the Better Value Option?
Blachem (BCPC) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of -1.10% and 3.57%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Blachem (BCPC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Blachem (BCPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MATV or BCPC: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MATV vs. BCPC: Which Stock Is the Better Value Option?
Do Options Traders Know Something About Balchem (BCPC) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Balchem (BCPC) stock based on the movements in the options market lately.
Blachem (BCPC) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of 16.25% and 4.05%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Blachem (BCPC) Lags Q1 Earnings Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of -10.26% and 0.23%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for April 25th
by Zacks Equity Research
BCPC, ASMIY and BRDG have been added to the Zacks Rank #5 (Strong Sell) List on April 25, 2023.
Blachem (BCPC) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of -26.67% and 4.47%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Quaker Chemical (KWR) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Quaker Chemical (KWR) delivered earnings and revenue surprises of 13.93% and 6.56%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Blachem (BCPC) Q3 Earnings Miss Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of -14.29% and 1.36%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Quaker Chemical (KWR) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Quaker Chemical (KWR) delivered earnings and revenue surprises of 21.68% and 1.88%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Nutrien (NTR) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Nutrien (NTR) delivered earnings and revenue surprises of -35.97% and 9.18%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Blachem (BCPC) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Blachem (BCPC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.